Amgen is searching for a Senior Counsel – Patent – Biosimilars in our Intellectual Property and Litigation group.
This role can be based at Amgen's corporate headquarters in THOUSAND OAKS, California or at Amgen's sites in SOUTH SAN FRANCISCO, California or CAMBRIDGE, Massachusetts. Preferably, this role will be based in THOUSAND OAKS.
The Senior Counsel will develop, implement and execute a market access strategy for Amgen’s biosimilar molecules, including freedom-to-operate analyses for drug substance, drug product, formulations, processes and labeled indications.
The Senior Counsel will work in all aspects of intellectual property, especially in identification of relevant patents, conducting searches for prior art, analyzing third party patents, developing persuasive legal arguments, drafting opinion, working with experts, and performing other pre-litigation activities.
Other responsibilities for the Senior Counsel could include related worldwide patent procurement, trademark and copyright matters, due diligence, and patent litigation support.
The Senior Counsel will work individually, in legal teams and in cross-functional business teams.
Amgen discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science’s promise by bringing safe, effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people’s lives.
Advancing science and helping patients - these dual passions are ingrained in our culture. They drive our work, our values, and everything we do at Amgen. For staff around the world, our mission to serve patients and our commitment to science makes Amgen a place where we can make a positive difference in people's lives while pursuing a challenging and fulfilling career. To foster a setting in which all staff may excel, we support a variety of growth opportunities—from training and education to expanding current job responsibilities.
Amgen's outstanding compensation package features comprehensive benefits. To learn more about this opportunity and to apply, please visit us online at http://careers.amgen.com/ and search job #R-60144.
Amgen is an Equal Opportunity employer and will consider all qualified applicants for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, or disability status.
J.D. degree or LL.M. degree from an accredited law school, admission to practice law in a U.S. jurisdiction and four (4) years of experience practicing intellectual property law
Registered to practice before the U.S. Patent and Trademark Office.
10+ years of experience practicing patent or intellectual property law
Experience in all aspects of U.S. and foreign intellectual property law relating to biotechnology at a law firm or biotechnology/pharmaceuticalcorporation
Experience in adversarial proceedings such as oppositions, IPRs, other post-grant proceedings, or litigation in the United States or other jurisdictions
An advanced degree, such as a Master’s or Ph.D., or research experience, in molecular biology, cell biology, microbiology, biochemistry, genetics, immunology, structural biology, pharmaceutics, chemical engineering or biology
Excellent judgment, analytical skills, legal drafting and oral and written communication skills
Strong management skills as well as a strong client service focus and the ability to work independently and in teams; ability to navigate through ambiguity, ability to work efficiently, to prioritize workflow, to meet demanding deadlines, and to manage multi-dimensional projects in a fast-paced environment
Internal Number: #R60144
Amgen is committed to unlocking the potential for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.